These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26285242)

  • 41. Colorectal cancer vaccines: The current scenario and future prospects.
    Jia W; Zhang T; Huang H; Feng H; Wang S; Guo Z; Luo Z; Ji X; Cheng X; Zhao R
    Front Immunol; 2022; 13():942235. PubMed ID: 35990683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The future of cancer vaccines against colorectal cancer.
    Jia W; Shen X; Guo Z; Cheng X; Zhao R
    Expert Opin Biol Ther; 2024 Apr; 24(4):269-284. PubMed ID: 38644655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden].
    Cohen R; Heran M; Pudlarz T; Hilmi M; Tournigand C; André T; Rousseau B
    Bull Cancer; 2019 Feb; 106(2):151-161. PubMed ID: 30638897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature.
    Sehdev A; Cramer HM; Ibrahim AA; Younger AE; O'Neil BH
    Discov Med; 2016 May; 21(117):341-7. PubMed ID: 27355330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotherapy in Colorectal Cancer.
    Copur MS
    Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of microsatellite stability status in colorectal cancer.
    Gupta R; Sinha S; Paul RN
    Curr Probl Cancer; 2018 Nov; 42(6):548-559. PubMed ID: 30119911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colorectal Cancer Immunotherapy: Options and Strategies.
    Johdi NA; Sukor NF
    Front Immunol; 2020; 11():1624. PubMed ID: 33042104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy of Colorectal Cancer.
    Jäger D; Halama N; Zörnig I; Klug P; Krauss J; Haag GM
    Oncol Res Treat; 2016; 39(6):346-50. PubMed ID: 27259331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer vaccines in clinical trials.
    Speetjens FM; Zeestraten EC; Kuppen PJ; Melief CJ; van der Burg SH
    Expert Rev Vaccines; 2011 Jun; 10(6):899-921. PubMed ID: 21692708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
    Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer.
    Mendonça Gorgulho C; Krishnamurthy A; Lanzi A; Galon J; Housseau F; Kaneno R; Lotze MT
    J Immunother; 2021 Feb-Mar 01; 44(2):49-62. PubMed ID: 33416261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Best supportive care in a young patient with locally advanced MSI-high colon cancer?].
    Welland S; De Castro T; Wirth T; Kleine M; Ringe KI; Saborowski A; Vogel A
    Z Gastroenterol; 2020 Sep; 58(9):872-876. PubMed ID: 32503059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advancements in combining targeted therapy and immunotherapy for colorectal cancer.
    Singh M; Morris VK; Bandey IN; Hong DS; Kopetz S
    Trends Cancer; 2024 Jul; 10(7):598-609. PubMed ID: 38821852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [IV. dMMR or MSI-H Colorectal Cancer].
    Sunakawa Y
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1602-1607. PubMed ID: 30449847
    [No Abstract]   [Full Text] [Related]  

  • 56. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
    Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
    Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.
    Berry J; Vreeland T; Trappey A; Hale D; Peace K; Tyler J; Walker A; Brown R; Herbert G; Yi F; Jackson D; Clifton G; Peoples GE
    Expert Rev Clin Immunol; 2017 Mar; 13(3):235-245. PubMed ID: 27552944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term prognosis for colorectal carcinoma treated with adjuvant immunochemotherapy].
    Sakai T; Yamashita Y
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():460-3. PubMed ID: 14574935
    [No Abstract]   [Full Text] [Related]  

  • 59. [Molecular pathogenesis. Its importance in targeted therapy in colorectal cancer].
    Kloor M; Michel S; von Knebel Doeberitz M
    Pathologe; 2008 Nov; 29 Suppl 2():196-9. PubMed ID: 18810440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal cancer.
    Nicum S; Midgley R; Kerr DJ
    Acta Oncol; 2003; 42(4):263-75. PubMed ID: 12899497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.